# C4 Therapeutics, Inc.: Form SC 13D/A, filed Jun 15, 2021

- Company: [C4 Therapeutics, Inc.](/companies/cccc.md) (CIK 1662579)
- Form: SC 13D/A
- Filed: 2021-06-15
- Accepted by EDGAR: Jun 15, 2021, 08:31 ET
- Period: not reported
- Accession: 0001193125-21-190646
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1662579/000119312521190646/d130114dsc13da.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1662579/000119312521190646/

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1662579/000119312521190646/d130114dsc13da.htm

Filed Jun 15, 2021.
Source: SEC EDGAR, the filing index for accession 0001193125-21-190646. Last ingested by Listed: Nov 14, 2026, 19:39 ET. No prices; not investment advice.
